Back
ClearPoint Neuro Vs. Perspective Therapeutics Industry Stock Comparison
Sell
29
CLPT
ClearPoint Neuro
Last Price:
5.99
Seasonality Move:
-6.05%
Buy
75
CATX
Perspective Therapeutics
Last Price:
1.74
Seasonality Move:
2.36%
Sell
29
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy, Sell or Hold?
- The current ClearPoint Neuro [CLPT] share price is $6.01. The Score for CLPT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- CLPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.76. The Score for CATX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLPT Stock Price Chart
What is ClearPoint Neuro's stock price today?
-
The ClearPoint Neuro share price today is $6.01
The current trend is relatively stagnant and CLPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.76
The current trend is moderately bullish and CATX is experiencing slight buying pressure.
CLPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 54.16 | Buy |
| Chaikin Money Flow: | 106367 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.38 - 5.96) | Buy |
| Bollinger Bands (100): | (5.9 - 7.3) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 61.92 | Buy |
| Chaikin Money Flow: | 2859580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Buy |
| Bollinger Bands (100): | (0.62 - 1.5) | Buy |
CLPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.94 | Buy |
| 20-day SMA: | 5.62 | Buy |
| 50-day SMA: | 6.13 | Sell |
| 200-day SMA: | 6.09 | Sell |
| 8-day EMA: | 5.88 | Buy |
| 20-day EMA: | 5.82 | Buy |
| 50-day EMA: | 6.08 | Sell |
| 200-day EMA: | 6.57 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.79 | Sell |
| 20-day SMA: | 1.68 | Buy |
| 50-day SMA: | 1.43 | Buy |
| 200-day SMA: | 0.69 | Buy |
| 8-day EMA: | 1.76 | Buy |
| 20-day EMA: | 1.68 | Buy |
| 50-day EMA: | 1.45 | Buy |
| 200-day EMA: | 0.89 | Buy |
ClearPoint Neuro Earnings Growth & CLPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.05 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ClearPoint Neuro Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||